drugset / Trial / NCT00994981

Magnesium Administration in Liver Transplantation and Reperfusion Injury

NCT00994981

Phase 4 Completed 61 enrolled The Catholic University of Korea
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to evaluate the effect of intravenous magnesium infusion before reperfusion with employing some clinical parameters including blood lactate levels, because the intraoperative changes in the blood lactate levels after hepatic allograft reperfusion served as an accurate predictor of the initial graft function in living donor liver transplantation.

Timeline

Start
2007-09
Primary completion
2008-09
Completion
2008-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Magnesium Sulfate Other / unclassified 25 mg/kg Intravenous

Indications

No indication recorded.